| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $36.5M | -9.6% |
| Cost of Revenue | $31.0M | -11.2% |
| Gross Profit | $5.5M | +0.7% |
| R&D Expense | $1.0M | -20.1% |
| SG&A Expense | $8.5M | +5.9% |
| Operating Income | -$4.3M | -9.6% |
| Pre-tax Income | -$3.9M | -72.1% |
| Income Tax | $0 | — |
| Net Income | -$3.9M | -72.1% |
| EPS (Basic) | -$0.19 | -46.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.4M | -10.4% |
| Short-term Investments | $7K | — |
| Accounts Receivable | $4.0M | -18.9% |
| Current Assets | $40.0M | -11.8% |
| Total Assets | $42.2M | -11.7% |
| Current Liabilities | $5.7M | -19.3% |
| Stockholders' Equity | $35.4M | -9.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.7M | +14.8% |
| Capital Expenditures | $522K | +10.1% |
| Investing Cash Flow | -$442K | +6.8% |
| Financing Cash Flow | -$259K | -100.8% |
| Free Cash Flow | -$4.2M | +12.3% |